Biotech Startups
10,099 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Vireo Health produces medical cannabis products organized into color-coded product lines (the Vireo Spectrum), with pharmacists recommending THC- or CBD-dominant options based on a patient's qualifying medical condition. It serves medical cannabis patients treating conditions such as chemotherapy-related nausea, epilepsy, and other neurological diseases.
0 investors
0 investors
0 investors
0 investors
0 investors
VirTech Bio develops OxyBridge, a human-derived hemoglobin-based oxygen carrier (HBOC) intended as a blood substitute for time-critical trauma patients in hemorrhagic shock and for pre-transplant donor organ perfusion. The product is aimed at military and civilian trauma care and organ transplantation, using an ultra-polymer design to deliver oxygen and maintain blood pressure without refrigeration.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
VIST Labs produces CryoPasteurization, a decontamination technology that removes harmful microbial contaminants from cannabis while preserving terpenes and cannabinoids for cultivators and producers. The pharmaceutical-grade process uses natural methods without chemicals or irradiation to help cannabis meet state testing standards.
0 investors
0 investors
Vita Imaging is a medical technology company developing AURA™, a non-invasive imaging and spectroscopy device that uses Raman spectroscopy and machine learning to distinguish benign from malignant skin lesions in real time for point-of-care cancer screening. It builds physician decision-support diagnostic systems aimed at healthcare providers for early cancer detection.
0 investors
0 investors
Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.
0 investors
0 investors
0 investors
Vitro Biopharma is a biotechnology company developing Wharton's jelly-derived (umbilical cord) mesenchymal stem cell therapies for autoimmune diseases and inflammatory disorders. It manufactures its cell therapy product candidates under cGMP conditions with ISO 9001:2015 and ISO 13485:2016 certification for the immunology and inflammation market.
0 investors
0 investors
Vitruvias Therapeutics was a pharmaceutical company; it has ceased operations, and its products are now owned and/or distributed by H2-Pharma LLC.
0 investors